Full Coverage

Barr, Teva climb on merger deal

Jul 18, 2008
Story Timeline:  174 days

BOSTON (MarketWatch) -- Drug stocks were mixed in early trading Friday as shares of Teva Pharmaceutical Industries and Barr Pharmacueticals gained on news they plan to merge. The Amex Pharmaceutical Index edged up 0.3% to 306.3 and the Amex Biotechnology Index eased 0.5% to 798.0. Teva said that it plans to buy rival generics maker Barr for about $7.46 billion in cash and stock, or about $66.50 a share. Shares of Barr shot up 9% to $62.47 as Teva shares rose 4% to... [read full story]                    

Add Comment
Latest article on this story:

Teva Pharmaceutical upgraded to buy at Deutsche Bank

pharmiweb.co.uk Jul 21, 2008
First article on this story:

Biotech Stocks: Teva, Barr climber on merger deal

marketwatch.com Jul 18, 2008
Selected publications with coverage of this story:
RELATED